Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




ASH 2008: Imatinib Can Be Discontinued in Some Patients With CML
Link ID 11349
Title ASH 2008: Imatinib Can Be Discontinued in Some Patients With CML
Url http://www.medscape.com/viewarticle/584961?src=rss
Description Imatinib therapy can be discontinued in patients with chronic myeloid leukemia who experience a complete molecular response; it does not automatically lead to relapse. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Dec 9, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Moderate Alcohol Intake and Cancer Incidence in Women
  Does low to moderate alcohol consumption in women increase the risk of certain cancers? How much is safe to drink with regard to cancer risk? Journal of the National Cancer Institute
Category:   Articles > Hematology-Oncology


2. After Complete Remission of Testicular Cancer, What Next?
  For patients with testicular cancer in complete remission, is a postchemotherapy retroperitoneal lymph node dissection needed? Dr. Howard Hochster reports on a study that answers this question. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


3. Urologists Not Fully Caring for Patients With Bladder Cancer?Urologists Not Fully Caring for Patient
  Patients with high-grade noninvasive bladder cancer rarely receive the care recommended in guidelines. br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology


4. Uncertainty Over Use of GnRH Agonists in Breast CancerUncertainty Over Use of GnRH Agonists in Breas
  A new study adds to conflicting data on the use of ovarian suppression during chemotherapy in premenopausal women with breast cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. "Significant Problem" With Nonadherence and Breast Cancer Hormonal Therapies
  A new study shows that women with breast cancer do not take adjuvant hormonal therapies as well as their doctors might hope. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS